2 registrations that name elderberry as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.
Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.
Filter 2 registrations
Status
All 2 registrations
Not yet recruitingNCT07054671
Effects of an Elderberry-Based Functional Beverage on Exercise Performance, Muscle Structure, and the Gut-Muscle Axis
No phase
Burdur Mehmet Akif Ersoy University
About 54 people
Starts Nov 1, 2025 (estimated)
In plain words A study of elderberry in people 18 to 45, run by Burdur Mehmet Akif Ersoy University. It plans to enroll about 54 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 to 45; healthy volunteers accepted. Conditions: Exercise; Anthocyanins; Muscle Size.
Engaging in regular physical activity at least 2 days per week
Body Mass Index (BMI) between 18.5 and 29.9 kg/m²
No use of antibiotics, probiotics, or prebiotics within the past 3 months
No history of chronic illness or autoimmune disorders
2 more inclusion criteria and the exclusion criteria are on the listing.
Introduction: Increasing sedentary lifestyle, microbiota imbalance and exercise-induced muscle fatigue are among the main causes of metabolic stress and performance decline, even in young individuals. The potential effects of functional foods-particularly polyphenol and anthocyanin-rich beverages-on both gut microbiota and muscle performance have attracted attention in recent years. In this context, intervention studies focused on the gut-muscle axis represent a promising and valuable area of research. The full summary is on the listing.
Where, as registered
No US site; Turkey (Türkiye) (1).
Not yet recruitingNCT07054645
Elderberry Functional Gum and Cognitive & Oral Health in Older Adults
No phase
Burdur Mehmet Akif Ersoy University
About 34 people
Starts Nov 1, 2025 (estimated)
In plain words A study of elderberry in people 65 and older, run by Burdur Mehmet Akif Ersoy University. It plans to enroll about 34 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 65 and older. Conditions: Mild Cognitive Impairment (MCI); Aging; Oral Microbiome.
Individuals aged 60 and over
Individuals with mildly reduced cognitive function using the MoCA test (MoCA score: 20-25)
Those with stable systemic diseases (e.g. HT, controlled DM)
Those with adequate dental health (≥20 natural teeth or no chewing problems with functional prosthesis)
2 more inclusion criteria and the exclusion criteria are on the listing.
Globally, the aging population is increasing rapidly, leading to a dramatic rise in the prevalence of Alzheimer's disease and other types of dementia. Neurodegenerative disorders are characterized by pathological hallmarks such as β-amyloid (Aβ) plaque accumulation, tau protein aggregation, synaptic loss, and widespread neuroinflammation. These processes impair key cognitive domains including attention, memory, executive function, and orientation, hindering independent daily functioning. The full summary is on the listing.